Physician profile
Steven B Ogden
NPI 1114123080
$35,878.86
in general payments reported to CMS, 2019-2025
14 companies · $3,419 in 2025
The $3,419 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $6,100 · 2021: $4,335 · 2022: $871 · 2023: $670 · 2024: $352 · 2025: $3,419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,559 · Travel and Lodging: $1,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,559.32 |
| Travel and Lodging | $1,881.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $30,084.27 | 2019-2025 | Tapestry, Rosa |
| Stryker Corporation | $5,193.75 | 2019-2025 | Mako, Variax, Triathlon |
| Alafair Biosciences, INC. | $122.82 | 2025 | Versawrap |
| Glaxosmithkline, LLC. | $106.33 | 2019-2025 | Trelegy Ellipta |
| Depuy Synthes Sales INC. | $100.73 | 2023-2025 | Na, Monovisc |
| Smith+Nephew, INC. | $68.86 | 2025 | Pico 7 |
| Ucb, INC. | $48.09 | 2024 | Nayzilam |
| Pylant Medical | $40.04 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $24.46 | 2025 | Exparel |
| Molnlycke Health Care US, LLC | $20.12 | 2023 | Avance, Mepilex Border Flex, Mepilex Border Post-Op |
| Heron Therapeutics, INC. | $19.71 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.58 | 2023 | Eliquis |
| Moximed, INC | $16.89 | 2023 | Misha Knee System |
| Ferring Pharmaceuticals INC. | $15.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Ogden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.